1. Home
  2. CORT vs CIEN Comparison

CORT vs CIEN Comparison

Compare CORT & CIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • CIEN
  • Stock Information
  • Founded
  • CORT 1998
  • CIEN 1992
  • Country
  • CORT United States
  • CIEN United States
  • Employees
  • CORT N/A
  • CIEN N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • CIEN Telecommunications Equipment
  • Sector
  • CORT Health Care
  • CIEN Utilities
  • Exchange
  • CORT Nasdaq
  • CIEN Nasdaq
  • Market Cap
  • CORT 7.6B
  • CIEN 12.8B
  • IPO Year
  • CORT N/A
  • CIEN 1997
  • Fundamental
  • Price
  • CORT $69.53
  • CIEN $135.95
  • Analyst Decision
  • CORT Strong Buy
  • CIEN Buy
  • Analyst Count
  • CORT 4
  • CIEN 15
  • Target Price
  • CORT $139.00
  • CIEN $113.96
  • AVG Volume (30 Days)
  • CORT 644.6K
  • CIEN 2.9M
  • Earning Date
  • CORT 10-29-2025
  • CIEN 09-04-2025
  • Dividend Yield
  • CORT N/A
  • CIEN N/A
  • EPS Growth
  • CORT N/A
  • CIEN 3.32
  • EPS
  • CORT 1.11
  • CIEN 0.98
  • Revenue
  • CORT $716,080,000.00
  • CIEN $4,541,635,000.00
  • Revenue This Year
  • CORT $30.62
  • CIEN $16.41
  • Revenue Next Year
  • CORT $37.68
  • CIEN $10.12
  • P/E Ratio
  • CORT $62.97
  • CIEN $138.20
  • Revenue Growth
  • CORT 25.71
  • CIEN 12.97
  • 52 Week Low
  • CORT $37.82
  • CIEN $49.21
  • 52 Week High
  • CORT $117.33
  • CIEN $138.35
  • Technical
  • Relative Strength Index (RSI)
  • CORT 45.26
  • CIEN 84.18
  • Support Level
  • CORT $67.32
  • CIEN $90.00
  • Resistance Level
  • CORT $74.79
  • CIEN $134.31
  • Average True Range (ATR)
  • CORT 2.36
  • CIEN 4.64
  • MACD
  • CORT 0.14
  • CIEN 3.61
  • Stochastic Oscillator
  • CORT 29.58
  • CIEN 95.03

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About CIEN Ciena Corporation

Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.

Share on Social Networks: